ImmuCell plans second expansion in three years as demand grows

ImmuCell has had a backlog of orders for its flagship product, First Defense. “Good problem to have,” says the company’s CEO.

Related Keywords

Canada ,Daniel Catlin ,Kristi Kenney ,Richard Mcgoldrick ,Michael Brigham ,Drug Administration ,Properties Management ,Energy Service ,Immucell Corp ,Nasdaq ,First Defense ,Riverside Street ,Commercial Properties ,French Construction ,